Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM
6 affiliations
- 1Mayo Clinic, Phoenix, AZ, USA
- 21The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3Ludwig-Maximilians University Munich, Munich, Bavaria, Germany
- 412 German Centre for Neurodegenerative Diseases, Munich, Germany
- 5German Center for Neurodegenerative Diseases (DZNE), Munich, Bavaria, Germany
- 6Denali Therapeutics, Inc., South San Francisco, CA, USA
Related
- Lymphatic pathways in antiviral immunity: from virion transport to host defense
- Digital Health-Enabled Prehospital Notification for Acute Stroke Using the Brain Saver Mobile App in Emergency Medical Transport in South Korea: Pilot Quasi-Experimental Study.
- LIPC-E97G Gain-of-function variant potentiates the hypocholesterolemic and anti-atherogenic effects of evinacumab in Ldlr-/- mice
- Acute Social Stress Potentiates Cue-Driven Behavior in Alcohol Use Disorder: Behavioral and Neural Evidence
- Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and Relapsed/Refractory AML
BibTeX
@article{gupta2026transport,
title = {{606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM}},
author = {Pravesh Gupta and Krishna Bhat and Christian Haass and Matthias Brendel and Tyler M Johnston and Yoshinari Osada and Gabrielle Kizeev and Kai Schlepckow and Kathryn Monroe},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0606},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0606},
note = {CC BY},
}
RIS
TY - JOUR
TI - 606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM
AU - Pravesh Gupta
AU - Krishna Bhat
AU - Christian Haass
AU - Matthias Brendel
AU - Tyler M Johnston
AU - Yoshinari Osada
AU - Gabrielle Kizeev
AU - Kai Schlepckow
AU - Kathryn Monroe
PY - 2026
DA - 2026/11/08
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0606
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0606
SN - 2051-1426
ER -